Prehospital management of uncontrolled bleeding in trauma patients: Nearing the light at the end of the tunnel

Israel Medical Association Journal

Volumn 6, Issue 8, 2004, Pages 485-489

  Soudry, Ethan ^a,b   Stein, Michael ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Hemoglobin solutions; Prehospital; Recombinant activated factor VI; Trauma; Uncontrolled bleeding

Indexed keywords

BLOOD SUBSTITUTE; DEXTRAN; DIASPIRIN CROSSLINKED HEMOGLOBIN; FLUOROCARBON; HEMOGLOBIN; HEMOSTATIC AGENT; HYPERTONIC SOLUTION; INFUSION FLUID; POLYMERIZED HEMOGLOBIN; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RECOMBINANT HEMOGLOBIN; RINGER LACTATE SOLUTION;

BLEEDING; BOVINE SPONGIFORM ENCEPHALOPATHY; CRYSTALLOID; DRUG BINDING; DRUG EFFICACY; DRUG FATALITY; DRUG METABOLISM; DRUG SAFETY; ERYTHROCYTE CONCENTRATE; FLU LIKE SYNDROME; GASTROINTESTINAL DISEASE; HUMAN; HYPERTENSION; INFECTION RISK; JAUNDICE; PATIENT CARE; RESUSCITATION; RETROSPECTIVE STUDY; REVIEW; SURGICAL PATIENT; THROMBOSIS; TRAUMATOLOGY;

BLOOD SUBSTITUTES; EMERGENCY TREATMENT; ERYTHROCYTE TRANSFUSION; HEMORRHAGE; HEMOSTATICS; HUMANS; RESUSCITATION; WOUNDS AND INJURIES;

EID: 4444320871     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. American College of Surgeons. Shock. In: Advanced Trauma Life Support for Doctors, 1997.
2. Bickell WH, Wall MJ Jr, Pepe PE, et al. Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries. N Engl J Med 1994;331:1105-9.
3. Kwan I, Bunn F, Roberts I. WHO Pre-Hospital Trauma Care Steering Committee. Timing and volume of fluid administration for patients with bleeding following trauma. Cochrane Database Syst Rev 2001;(1):CD002245.
4. Krausz MM, Bashenko Y, Hirsh M. Crystalloid and colloid resuscitation of uncontrolled hemorrhagic shock following massive splenic injury. Shock 2001;16:383-8.
5. Solomonov E, Hirsh M, Yahiya A, Krausz MM. The effect of vigorous fluid resuscitation in uncontrolled hemorrhagic shock after massive splenic injury. Crit Care Med 2000;28:749-54.
6. Krausz MM, Bashenko Y, Hirsh M. Crystalloid or colloid resuscitation of uncontrolled hemorrhagic shock after moderate splenic injury. Shock 2000;13:230-5.
7. Burris D, Rhee P, Kaufman C, et al. Controlled resuscitation for uncontrolled hemorrhagic shock. J Trauma 1999;46:216-23.
8. Mattox KL, Maningas PA, Moore EE, et al. Prehospital hypertonic saline/dextran infusion for post-traumatic hypotension. The USA Multicenter Trial. Ann Surg 1991;213:482-91.
9. Vassar MJ, Fischer RP, O'Brien PE, et al. A multicenter trial for resuscitation of injured patients with 7.5% sodium chloride. The effect of added dextran 70. The Multicenter Group for the Study of Hypertonic Saline in Trauma Patients. Arch Surg 1993;128:1003-11.
10. Wade CE, Kramer GC, Grady JJ, Fabian TC, Younes RN. Efficacy of hypertonic 7.5% saline and 6% dextran-70 in treating trauma: a meta-analysis of controlled clinical studies. Surgery 1997;22:609-16.
11. Mauritz W, Schimetta W, Oberreither S, Polz W. Are hypertonic hyperoncotic solutions safe for prehospital small-volume resuscitation? Results of a prospective observational study. Eur J Emerg Med 2002;9:315-19.
12. Wade CE, Grady JJ, Kramer GC. Efficacy of hypertonic saline dextran fluid resuscitation for patients with hypotension from penetrating trauma. J Trauma 2003;54:s144-8.
13. Butler E. Preservation and clinical use of erythrocytes and whole blood. In: Beutler E, Lichtman M, Coller BS, Kipps TJ, Seligsohn U, eds. Williams Hematology. 6th edn. New York: McGraw-Hill Book Co., 2001:1879-92.
14. Barkana Y, Stein M, Maor R, Lynn M, Eldad A. Prehospital blood transfusion in prolonged evacuation. J Trauma 1999;46:176-80.
15. Remy B, Deby-Dupont G, Lamy M. Red blood cell substitutes: fluorocarbon emulsions and hemoglobin solutions. Br Med J 1999; 5:277-98
16. Gould S, Rosen A, Sehgal L, et al. Polymerized pyridoxilated hemoglobin: efficacy as an oxygen carrier. J Trauma 1986;26:903-8.
17. Spahn DR, Waschke KF, Standl T, et al. Use of perflubron emulsion to decrease allogenic blood transfusion in high-blood-loss non-cardiac surgery: results of a European phase 3 study. Anesthiology 2002;97: 1338-49.
18. Cheng DCH. Safety and efficacy of o-raffinose cross-linked human hemoglobin [Hemolink™] in cardiac surgery [Review]. Can J Anesth 2001;48:s41-8.
19. Hill SE. Oxygen therapeutics - current concepts [Review]. Can J Anesth 2001;48:s32-40.
20. Lou Carmichael FJ, Ali ACY, Campbell JA, et al. A phase I study of oxidized raffinose cross-linked human hemoglobin. Crit Care Med 2000;28:2283-92.
21. Manning JE, Katz LM, Brownstein MR, Pearce LB, Gawryl MS, Baker CC. Bovine hemoglobin-based oxygen carrier (HBOC-201) for resuscitation of uncontrolled, exsanguinating liver injury in swine. Carolina Resuscitation Research Group. Shock 2000;13:152-9.
22. Knudson MM, Lee S, Erickson V, Morabito D, Derugin N, Manley GT. Tissue oxygen monitoring during hemorrhagic shock and resuscitation: a comparison of lactated Ringer's solution, hypertonic saline dextran, and HBOC-201. J Trauma 2003;54:242-52.
23. Sloan EP, Koenigsberg M, Gens D, et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA 1999;282:1857-64.
24. Kerner T, Ahlers O, Veit S, Riou B, Saunders M, Pison U. DCL-Hb for trauma patients with severe hemorrhagic shock: the European "On Scene" Multicenter Study. Intensive Care Med 2003; 29:378-85.
25. LaMuraglia GM, O'Hara PJ, Baker WH, et al. The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution. J Vasc Surg 2000;31:299-308.
26. Gould SA, Moore EE, Hoyt DB, et al. The first randomized trial of human poymerized hemoglobin as a blood substitute in acute trauma and emergent surgery. J Am Coll Surg 1998;187:113-20.
27. Gould SA, Moore EE, Hoyt DB, et al. The life-sustaining capacity of human polymerized hemoglobin when red cells might be unavailable. J Am Coll Surg 2002;195:445-52.
28. Kenet G, Walden R, Eldad A, Martinowits U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet 1999;354:1879.
29. Martinowits U, Kenet G, Segal E, et al. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001;51:431-8.
30. O'Neill PA, Bluth M, Gloster ES. Successful use of recombinant activated factor VII for trauma in a patient without preexisting coagulopathy. J Trauma 2002;52:400-5.
31. Martinowits U, Kenet G, Lubetski A, Luboshitz J, Segal E. Possible role of recombinant activated factor VII (rFVIIa) in the control of hemorrhage associated with massive trauma. Can J Anesthesia 2002;49:s15-20.
32. Martinowitz U, Holocomb JB, Pusateri AE, et al. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries. J Trauma 2001;50:721-9.
33. Lynn M, Jerokhimov I, Jewelewicz D, et al. Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock: a pilot study. J Trauma 2002;52:703-7.
34. Jeroukhimov I, Jewelewicz D, Zaias J, et al. Early injection of high dose recombinant factor VIIa decreases blood loss and prolongs time from injury to death in experimental liver injury, J Trauma 2002;53:1053-7.
35. Arnold BD, Minei JP. Potential of hemoglobin-based oxygen carriers in trauma patients. Curr Opin Crit Care 2001;7:431-6.
36. Levy JH. The use of haemoglobin glutamer-250 (HBOC-201) as an oxygen bridge in patients with acute anaemia associated with surgical blood loss. Expert Opin Biol Ther 2003;3:509-17.
37. Boura C, Caron A, Longois D, Mertes PM, Labrude P, Menu P. Volume expansion with modified hemoglobin solution, colloids, or crystalloid after hemorrhagic shock in rabbits: effects on skeletal muscle oxygen pressure and use versus arterial blood velocity and resistance. Shock 2003;19:176-82.
38. Lee SK, Morabito D, Hemphill JC, et al. Small-volume resuscitation with HBOC-201: effects on cardiovascular parameters and brain tissue oxygen tension in an out-of-hospital model of hemorrhage in swine. Acad Emerg Med 2002;9:969-76.
39. Katz LM, Manning JE, McCurdy S, et al. and the Carolina Resuscitation Research Group. HBOC-201 improves survival in a swine model of hemorrhagic shock and liver injury. Resuscitation 2002;54:77-87.
40. Resta TC, Walker BR, Eichinger MR, Doyle MP. Rate of NO scavenging alters effects of recombinant hemoglobin solutions on pulmonary vasoreactivity. J Appl Physiol 2002;93:1327-36.